INBX
Inhibrx Biosciences, Inc. (INBX)
NASDAQ · Healthcare
Inhibrx Biosciences, Inc. annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Inhibrx Biosciences, Inc. revenue for the quarter ending September 30, 2025 was 0.
- Inhibrx Biosciences, Inc. revenue for the twelve months ending September 30, 2025 was 1.3 M, a 422.09% increase year-over-year.
- Inhibrx Biosciences, Inc. annual revenue for 2025 was 1.3 M, a 550.00% increase from 2024.
- Inhibrx Biosciences, Inc. annual revenue for 2024 was 200000, a 88.89% decrease from 2023.
- Inhibrx Biosciences, Inc. annual revenue for 2023 was 1.8 M.
Revenue
TRAILING 12 MONTHS · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Inhibrx Biosciences, Inc. Earnings — FAQ
Inhibrx Biosciences, Inc. (INBX) earnings over the last 3 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see INBX's earnings history?
The chart and table above show Inhibrx Biosciences, Inc.'s earnings by year and by quarter, including the growth rate.